Double blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis [NCT00317629]

BACKGROUND: Cutaneous Leishmaniasis is a worldwide disease, endemic in 88 countries, that has shown an increasing incidence over the last two decades. So far, pentavalent antimony compounds have been considered the treatment of choice, with a percentage of cure of about 85%. However, the high effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Sandra Y, Rueda, Ligia C, López, Marcos, Vélez, Iván D, Rueda-Clausen, Christian F, Smith, Daniel J, Muñoz, Gerardo, Mosquera, Hernando, Silva, Federico A, Buitrago, Adriana, Díaz, Holger, López-Jaramillo, Patricio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524981/
https://www.ncbi.nlm.nih.gov/pubmed/16700912
http://dx.doi.org/10.1186/1745-6215-7-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524981/
https://www.ncbi.nlm.nih.gov/pubmed/16700912
http://dx.doi.org/10.1186/1745-6215-7-14

Ejemplares similares